Non‐thermal atmospheric plasma treatment of onychomycosis in an in vitro human nail model

BACKGROUND: Onychomycosis affects almost 6% of the world population. Topical azoles and systemic antifungal agents are of low efficacy and can have undesirable side effects. An effective, non‐invasive therapy for onychomycosis is an unmet clinical need. OBJECTIVE: Determine the efficacy threshold of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulson, Jeffry M., Liveris, Dionysios, Derkatch, Irina, Friedman, Gary, Geliebter, Jan, Park, Sin, Singh, Sarnath, Zemel, Marc, Tiwari, Raj K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003814/
https://www.ncbi.nlm.nih.gov/pubmed/31677288
http://dx.doi.org/10.1111/myc.13030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003814/
https://www.ncbi.nlm.nih.gov/pubmed/31677288
http://dx.doi.org/10.1111/myc.13030

Ejemplares similares